The report covers forecast and analysis for the pharmaceutical continuous manufacturing market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pharmaceutical continuous manufacturing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmaceutical continuous manufacturing market on a global level.
In order to give the users of this report a comprehensive view of the pharmaceutical continuous manufacturing market, we have included competitive landscape and analysis of Porter's Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein application, distribution channel, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, application portfolio of various companies according to region.
The study provides a decisive view of the pharmaceutical continuous manufacturing market by segmenting the market based on application type, distribution channel, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on application, the market is segmented into active pharmaceutical ingredient, biologics, and dry powders. Based on distribution channel type, the market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The end-users are classified into pharmaceutical companies and contract manufacturing organization. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of Middle East and Africa. This segmentation includes demand for pharmaceutical continuous manufacturing market based on individual application type, distribution channel, and end-users in all the regions and countries.
The report also includes detailed profiles of end players such as Siemens AG, Corning Life Sciences, S K Biotek Ltd., Scott Equipment Company, GEA Group, Korsch AG, Chemtrix, and Continuus Pharmaceuticals, among others.
This report segments the global pharmaceutical continuous manufacturing market as follows:
Global Pharmaceutical Continuous Manufacturing Market: Application Segment Analysis
- Active Pharmaceutical Ingredient
- Biologics
- Dry Powders
Global Pharmaceutical Continuous Manufacturing Market: Distribution Channel Segment Analysis
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Pharmaceutical Continuous Manufacturing Market: End-user Segment Analysis
- Pharmaceutical Companies
- Contract Manufacturing Organization
Global Pharmaceutical continuous manufacturing Market: Regional
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
